Sunday, September 9, 2012

Egypt: H5N1 Vaccine Updates

[We don't get much news out of Egypt these days. I don't believe for one minute that it is because Avian Influenza disappeared. Here are a few excerpts that are fairly recent]
 September 04, 2012
Second Birth veterinary vaccine industry in Egypt

On the other side, the strains of viruses that use global companies strains old does not fit the problems and strains in poultry farms Egyptian, which became a high intensity which occurred where a lot of changes in their properties and their structures, and this may explain poor efficiency vaccines currently used and their inability to immunize birds against viral strains that have become Tsol and toured poultry farms freely and without the presence of vaccines deterrent to get rid of these farms which suffered heavy losses reached last winter and many of the farms to 90% as the deaths of between broiler flocks.

Is The New Colossus, which is built in Sixth of October City investments exceeding 120 million pounds fully funded from a limited number of private investors, and so on an area of over 15 thousand square meters with the latest manufacturing technology live vaccines and oily used globally, and this is done with the latest isolated local covering all types of vaccines needed by the poultry industry in Egypt.

The Egyptian Company is a twin company Meevak where they two companies are complementary and are not competing. The company aims to Egyptian Industries biological and pharmaceutical production somewhere between 15 and 20% of the vaccines needed by the poultry industry in Egypt as well as a significant proportion of the vaccines needed by livestock, and use to fulfill their mission of these professors specialists in various fields to manufacture veterinary vaccines, and thus quantum of production is the largest plant for the production of veterinary vaccines in the Middle East but also in Africa.

 It has been necessary to achieve the production volume target that the company Egyptian create farm multiple dwellings to produce eggs free of pathogens and that production capacity exceeding 6 million eggs annually in the first stage increase to 9 million eggs at the production stage II, and thus put Egypt ranked second in the world in the production of this quality high-cost, high technology of this egg, which is the foundation of any attempt to manufacture veterinary vaccines or Adamic, after the United States. 


No comments: